Department of General Surgery, the Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Department of Hematology, the Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Public Health. 2024 Dec;237:336-343. doi: 10.1016/j.puhe.2024.10.033. Epub 2024 Nov 7.
This study aimed to assess the disease burden of cancer in young adults globally and the changes between 2012 and 2022.
A comprehensive analysis of global cancer statistics of young adults based on data provided by GLOBOCAN 2022.
The incidence and mortality estimates for cancer in young adults in 2012 and 2022 were obtained from the publication by Fidler et al. and GLOBOCAN 2022, respectively. Data were displayed descriptively and compared at the sex, global, regional, national and human development index (HDI) levels. Associations between HDI rank and cancer incidence and mortality were explored by Pearson correlation analysis.
In 2022, the number of new cancer cases and deaths in young adults were estimated to be 1,227,907 and 349,550, respectively, with the age-standardised incidence rate (ASIR) and age-standardised mortality rate (ASMR) of 49.5 and 14.2 per 100,000 population. In young adults, 47.22 % of new cases were breast, thyroid and cervical cancer, while the leading causes of cancer-related death were breast, leukaemia and cervical cancer. Compared to 2012, the number of new cases and the ASIR increased by 25.89 % and 14.32 %, respectively, while the number of deaths and the ASMR decreased by 2.03 % and 10.69 %, respectively. However, cancer burden and its changes varied substantially across geographical regions, HDI levels and cancer types. In general, infection-related cancers were more common in less developed regions, but their incidence decreased significantly, while Westernised lifestyle-related cancers were more common in developed countries and their incidence is increasing.
Cancer contributes substantially to health-related burdens in young adults and the overall incidence has increased dramatically in the past decade. However, the incidence and mortality of cancer in this age group varied considerably by sex, cancer type, region, country and HDI level.
本研究旨在评估全球青年人群癌症的疾病负担以及 2012 年至 2022 年期间的变化情况。
基于 GLOBOCAN 2022 提供的数据,对全球青年人群癌症统计数据进行综合分析。
分别从 Fidler 等人的出版物和 GLOBOCAN 2022 中获取 2012 年和 2022 年青年人群癌症的发病率和死亡率估计值。通过描述性分析,在性别、全球、区域、国家和人类发展指数(HDI)水平上进行比较。通过 Pearson 相关分析探讨 HDI 排名与癌症发病率和死亡率之间的关系。
2022 年,青年人群新发癌症病例和死亡病例估计数分别为 1227907 例和 349550 例,年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)分别为 49.5/100000 和 14.2/100000。在青年人群中,47.22%的新发病例为乳腺癌、甲状腺癌和宫颈癌,而导致癌症相关死亡的主要原因是乳腺癌、白血病和宫颈癌。与 2012 年相比,新发病例数和 ASIR 分别增加了 25.89%和 14.32%,而死亡病例数和 ASMR 分别下降了 2.03%和 10.69%。然而,癌症负担及其变化在地理区域、HDI 水平和癌症类型方面存在显著差异。一般来说,欠发达地区感染相关癌症更为常见,但发病率显著下降,而西方化生活方式相关癌症在发达国家更为常见,发病率呈上升趋势。
癌症对青年人群的健康相关负担有重大影响,过去十年中整体发病率显著增加。然而,该年龄组的癌症发病率和死亡率在性别、癌症类型、地区、国家和 HDI 水平方面存在较大差异。